Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 15 March 2024.Powered by Capital Market - Live News

Net profit of Mangalam Drugs and Organics rose 16.28% to Rs 0.50 crore in the quarter ended December 2023 as against Rs 0.43 crore during the previous quarter ended December 2022. Sales rose 54.22% to Rs 97.05 crore in the quarter ended December 2023 as against Rs 62.93 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales97.0562.93 54 OPM %7.1810.30 - PBDT3.663.39 8 PBT0.040.51 -92 NP0.500.43 16 Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 13 February 2024.Powered by Capital Market - Live News

Net loss of Mangalam Drugs and Organics reported to Rs 3.56 crore in the quarter ended September 2023 as against net profit of Rs 2.23 crore during the previous quarter ended September 2022. Sales declined 23.50% to Rs 81.37 crore in the quarter ended September 2023 as against Rs 106.37 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales81.37106.37 -24 OPM %2.697.94 - PBDT-1.025.89 PL PBT-4.753.13 PL NP-3.562.23 PL Powered by Capital Market - Live News

Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 8 November 2023.Powered by Capital Market - Live News